Collegium Pharmaceutical (COLL) Selling, General & Administrative (2014 - 2026)
Collegium Pharmaceutical (COLL) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn | 106.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.59 Mn |
| Mar 31, 2026 | 86.35 Mn |
| Dec 31, 2025 | 67.64 Mn |
| Sep 30, 2025 | 67.10 Mn |
| Jun 30, 2025 | 73.64 Mn |
| Mar 31, 2025 | 76.42 Mn |
| Dec 31, 2024 | 63.09 Mn |
| Sep 30, 2024 | 61.96 Mn |
| Jun 30, 2024 | 43.34 Mn |
| Mar 31, 2024 | 41.98 Mn |
| Dec 31, 2023 | 32.94 Mn |
| Sep 30, 2023 | 35.30 Mn |
| Jun 30, 2023 | 38.19 Mn |
| Mar 31, 2023 | 52.78 Mn |
| Dec 31, 2022 | 38.03 Mn |
| Sep 30, 2022 | 38.37 Mn |
| Jun 30, 2022 | 41.25 Mn |
| Mar 31, 2022 | 54.53 Mn |
| Dec 31, 2021 | 26.60 Mn |
| Sep 30, 2021 | 30.51 Mn |